Gujarat Terce Laboratories Ltd

GUJTERC
Health CarePharmaceuticals
SmallcapWith a market cap of ₹10 cr, stock is ranked 3,276
High RiskStock is 3.69x as volatile as Nifty
13.650.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹10 cr, stock is ranked 3,276
High RiskStock is 3.69x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-4.02
PB RatioPB Ratio
1.32
Dividend YieldDiv. Yield
Sector PESector PE
38.74
Sector PBSector PB
5.18
Sector Div YldSctr Div Yld
0.66%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Gujarat Terce Laboratories is engaged in manufacturing of tablets, capsules, and syrup and injection pertaining to the product group pharmaceuticals.

Investor PresentationView older 

Oct 28, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201820192020202129.4231.3537.8325.980.260.430.27-2.52
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Result 
Announced OnOct 30, 2021

GUJARAT TERCE LABORATORIES LTD. - 524314 - Corrigendum To Unaudited Financial Results Of The Company For The Quarter And Half-Year Ended On 30°" September 2021 W.R.T Cash Flow Statement | Download

GUJARAT TERCE LABORATORIES LTD. - 524314 - Corrigendum To Unaudited Financial Results Of The Company For The Quarter And Half-Year Ended On 30°" September 2021 W.R.T Cash Flow Statement | Download

Result 
Announced OnOct 30, 2021

Gujarat Terce Laboratories Ltd - 524314 - Corrigendum To Unaudited Financial Results Of The Company For The Quarter And Half-Year Ended On 30°" September 2021 W.R.T Cash Flow Statement | Download

Gujarat Terce Laboratories Ltd - 524314 - Corrigendum To Unaudited Financial Results Of The Company For The Quarter And Half-Year Ended On 30°" September 2021 W.R.T Cash Flow Statement | Download

Result 
Announced OnOct 29, 2021

GUJARAT TERCE LABORATORIES LTD. - 524314 - Disclosure Pursuant To Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 | Download

GUJARAT TERCE LABORATORIES LTD. - 524314 - Disclosure Pursuant To Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 | Download

See all events